Bile Duct Cancer Drug Market Size, Share, And Growth Report 2032
Bile Duct Cancer Drug Market by Type (5-fluorouracil (5-FU), Gemcitabine, Cisplatin, Capecitabine, Oxaliplatin, and Others), by Application (Hospitals, Clinics, and Others), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024–2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.78 Billion | USD 5.80 Billion | 8.5% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Bile Duct Cancer Drug Market, 2017 - 2024 (USD Million)
- 2.2. Global Bile Duct Cancer Drug Market: Snapshot
- Chapter 3. Bile Duct Cancer Drug Market - Industry Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global Bile Duct Cancer Drug Market drivers: Impact analysis
- 3.2.2. The worldwide growing prevalence of bile duct cancer
- 3.2.3. Technological improvement in the health care sector
- 3.3. Market Restraints
- 3.3.1. High-cost cancer treatment in the developed region as well as the high cost associated with clinical trials
- 3.3.2. long duration in approvals of drug
- 3.4. Opportunities
- 3.4.1. An increasing prevalence of cancer and the need for combination therapies
- 3.5. Porter's Five Forces analysis
- 3.5.1. Bargaining power of suppliers
- 3.5.2. Bargaining power of buyers
- 3.5.3. The threat from new entrants
- 3.5.4. The threat from new substitutes
- 3.5.5. Degree of competition
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by Type
- 3.6.2. Market attractiveness analysis, by Application
- 3.6.3. Market attractiveness analysis, by Region
- Chapter 4. Global Bile Duct Cancer Drug Market - Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global Bile Duct Cancer Drug Market: company market share, 2017
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Product Launch
- 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
- 4.2.4. Research and Development, and Regional Expansion
- 4.1. Company Market Share Analysis
- Chapter 5. Global Bile Duct Cancer Drug Market - Type Analysis
- 5.1. Global Bile Duct Cancer Drug Market: Type overview
- 5.1.1. Global Bile Duct Cancer Drug Market revenue share, by Type, 2017 and 2024(USD Million)
- 5.2. 5-fluorouracil (5-FU)
- 5.2.1. Global 5-fluorouracil (5-FU)market, 2017 - 2024(USD Million)
- 5.3. Gemcitabine
- 5.3.1. Global Gemcitabine market, 2017 - 2024(USD Million)
- 5.4. Cisplatin
- 5.4.1. Global Cisplatin market, 2017 - 2024(USD Million)
- 5.5. Capecitabine
- 5.5.1. Global Capecitabine market, 2017 - 2024(USD Million)
- 5.6. Oxaliplatin
- 5.6.1. Global Oxaliplatin market, 2017 - 2024(USD Million)
- 5.7. Others
- 5.7.1. Global Others market, 2017 - 2024(USD Million)
- 5.1. Global Bile Duct Cancer Drug Market: Type overview
- Chapter 6. Global Bile Duct Cancer Drug Market - Application Analysis
- 6.1. Global Bile Duct Cancer Drug Market: Application overview
- 6.1.1. Global Bile Duct Cancer Drug Market revenue share, by Application, 2017 and 2024(USD Million)
- 6.2. Hospitals
- 6.2.1. Global Bile Duct Cancer Drug Market for Hospitals, 2017 - 2024(USD Million)
- 6.3. Clinics
- 6.3.1. Global Bile Duct Cancer Drug Market for Clinics, 2017 - 2024(USD Million)
- 6.4. Others
- 6.4.1. Global Bile Duct Cancer Drug Market for Others, 2017 - 2024(USD Million)
- 6.1. Global Bile Duct Cancer Drug Market: Application overview
- Chapter 7. Global Bile Duct Cancer Drug Market - Regional Analysis
- 7.1. Global Bile Duct Cancer Drug Market: Regional overview
- 7.1.1. Global Bile Duct Cancer Drug Market revenue share, by Region, 2015 and 2024
- 7.2. North America
- 7.2.1. North America Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.2.2. North America Bile Duct Cancer Drug Market revenue, by Application, 2017 - 2024(USD Million)
- 7.2.2.1. The U.S.
- 7.2.2.1.1. The U.S. Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.2.2.1.2. The U.S. Bile Duct Cancer Drug Market revenue, by Application, 2017 - 2024(USD Million)
- 7.2.2.2. Rest of North America
- 7.2.2.2.1. Rest of North America Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.2.2.2.2. Rest of North America Bile Duct Cancer Drug Market revenue, by Application, 2017 - 2024(USD Million)
- 7.2.2.1. The U.S.
- 7.3. Europe
- 7.3.1. Europe Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.3.2. Europe Bile Duct Cancer Drug Market revenue, by Application, 2017 - 2024(USD Million)
- 7.3.3. Germany
- 7.3.3.1. Germany Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.3.3.2. Germany Bile Duct Cancer Drug Market revenue, by Application, 2017 - 2024(USD Million)
- 7.3.4. U.K.
- 7.3.4.1. U.K. Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.3.4.2. U.K. Bile Duct Cancer Drug Market revenue, by Application, 2017 - 2024(USD Million)
- 7.3.5. France
- 7.3.5.1. France Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.3.5.2. France Bile Duct Cancer Drug Market revenue, by Application, 2017 - 2024(USD Million)
- 7.3.6. Rest of Europe
- 7.3.6.1. Rest of Europe Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.3.6.2. Rest of Europe Bile Duct Cancer Drug Market revenue, by Application, 2017 - 2024(USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.4.2. Asia Pacific Bile Duct Cancer Drug Market revenue, Application, 2017 - 2024(USD Million)
- 7.4.3. China
- 7.4.3.1. China Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.4.3.2. China Bile Duct Cancer Drug Market revenue, by Application, 2017 - 2024(USD Million)
- 7.4.4. Japan
- 7.4.4.1. Japan Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.4.4.2. Japan Bile Duct Cancer Drug Market revenue, by Application, 2017 - 2024(USD Million)
- 7.4.5. India
- 7.4.5.1. India Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.4.5.2. India Bile Duct Cancer Drug Market revenue, by Application, 2017 - 2024(USD Million)
- 7.4.6. Rest of Asia Pacific
- 7.4.6.1. Rest of Asia Pacific Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.4.6.2. Rest of Asia Pacific Bile Duct Cancer Drug Market revenue, by Application, 2017 - 2024(USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.5.2. Latin America Bile Duct Cancer Drug Market revenue, by Application, 2017 - 2024(USD Million)
- 7.5.3. Brazil
- 7.5.3.1. Brazil Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.5.3.2. Brazil Bile Duct Cancer Drug Market revenue, by Application, 2017 - 2024(USD Million)
- 7.5.4. Rest of Latin America
- 7.5.4.1. Rest of Latin America Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.5.4.2. Rest of Latin America Bile Duct Cancer Drug Market revenue, by Application, 2017 - 2024(USD Million)
- 7.6. The Middle East and Africa
- 7.6.1. The Middle East and Africa Bile Duct Cancer Drug Market revenue, by Type, 2017 - 2024(USD Million)
- 7.6.2. The Middle East and Africa Bile Duct Cancer Drug Market revenue, by Application, 2017 - 2024(USD Million)
- 7.1. Global Bile Duct Cancer Drug Market: Regional overview
- Chapter 8. Company Profile
- 8.1. Delcath Systems Inc.
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Therapy portfolio
- 8.1.4. Business strategy
- 8.1.5. Recent developments
- 8.2. Accord Healthcare
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Therapy portfolio
- 8.2.4. Business strategy
- 8.2.5. Recent developments
- 8.3. F. Hoffmann-La Roche Ltd.
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Therapy portfolio
- 8.3.4. Business strategy
- 8.3.5. Recent developments
- 8.4. Pfizer Inc.
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Therapy portfolio
- 8.4.4. Business strategy
- 8.4.5. Recent developments
- 8.5. Teva Pharmaceutical Industries Ltd.
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Therapy portfolio
- 8.5.4. Business strategy
- 8.5.5. Recent developments
- 8.6. Bristol-Myers Squibb Company
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Therapy portfolio
- 8.6.4. Business strategy
- 8.6.5. Recent developments
- 8.7. Eli Lilly and Company
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Therapy portfolio
- 8.7.4. Business strategy
- 8.7.5. Recent developments
- 8.8. Mylan N.V.
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Therapy portfolio
- 8.8.4. Business strategy
- 8.8.5. Recent developments
- 8.9. Fresenius Kabi AG
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Therapy portfolio
- 8.9.4. Business strategy
- 8.9.5. Recent developments
- 8.10. Intercept Pharmaceuticals, Inc.
- 8.10.1. Overview
- 8.10.2. Financials
- 8.10.3. Therapy portfolio
- 8.10.4. Business strategy
- 8.10.5. Recent developments
- 8.1. Delcath Systems Inc.
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Bile Duct Cancer Drug Market revenue, 2017 – 2024 (USD Million)
4. Porter’s Five Forces Analysis
5. Bile Duct Cancer Drug Market attractiveness analysis, by Type
6. Bile Duct Cancer Drug Market attractiveness analysis, by Application
7. Bile Duct Cancer Drug Market: Market attractiveness analysis, by region
8. Company market share analysis, 2015
9. Global Bile Duct Cancer Drug Market revenue share by Type, 2017 and 2024
10. Global Bile Duct Cancer Drug Market, 2017 – 2024 (USD Million)
a. Global 5-fluorouracil (5-FU)market, 2017 – 2024(USD Million)
b. Global Gemcitabine market, 2017 – 2024(USD Million)
c. Global Cisplatin market, 2017 – 2024(USD Million)
d. Global Capecitabine market, 2017 – 2024(USD Million)
e. Global Oxaliplatin market, 2017 – 2024(USD Million)
f. Global Others market, 2017 – 2024(USD Million)
11. Global Bile Duct Cancer Drug Market revenue share by Application, 2017 and 2024
12. Global Bile Duct Cancer Drug Market, 2017 – 2024 (USD Million)
a. Hospitals, 2017 – 2024(USD Million)
b. Clinics, 2017 – 2024(USD Million)
c. Others, 2017 – 2024(USD Million)
Table Of Tables
List of Tables
1. Bile Duct Cancer Drug Market: Market Snapshot
2. Drivers of global Bile Duct Cancer Drug Market: Impact analysis
3. Restraints of Bile Duct Cancer Drug Market: Impact analysis
4. North America Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
5. North America Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
6. The U.S. Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
7. The U.S. Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
8. Rest of North America Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
9. Rest of North America Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
10. Europe Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
11. Europe Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
12. Germany Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
13. Germany Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
14. UK Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
15. UK Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
16. France Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
17. France Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
18. Rest of Europe Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
19. Rest of Europe Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
20. Asia Pacific Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
21. Asia Pacific Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
22. China Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
23. China Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
24. Japan Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
25. Japan Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
26. India Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
27. India Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
28. Rest of Asia Pacific Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
29. Rest of Asia Pacific Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
30. Latin America Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
31. Latin America Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
32. Brazil Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
33. Brazil Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
34. Rest of Latin America Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
35. Rest of Latin America Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
36. The Middle East and Africa Bile Duct Cancer Drug Market revenue, by Type, 2017 – 2024(USD Million)
37. The Middle East and Africa Bile Duct Cancer Drug Market revenue, by Application, 2017 – 2024(USD Million)
Methodology
FrequentlyAsked Questions
Bile duct connects the liver to the gallbladder and carries the fluid called bile, which is synthesized by the liver and stored in the gallbladder. The key function of bile is to break fats and help in digestion.
According to study, the Bile Duct Cancer Drug Market size was worth around USD 2.78 billion in 2023 and is predicted to grow to around USD 5.80 billion by 2032.
The CAGR value of Bile Duct Cancer Drug Market is expected to be around 8.5% during 2024-2032.
Asia Pacific has been leading the Bile Duct Cancer Drug Market and is anticipated to continue on the dominant position in the years to come.
The Bile Duct Cancer Drug Market is led by players like Delcath Systems Inc., Accord Healthcare, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Pfizer Inc., Eli Lilly and Company, Mylan N.V, Fresenius Kabi AG, Intercept Pharmaceuticals, Inc., and Celgene Corporation, among others.
Choose License Type
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed